Your browser doesn't support javascript.
loading
Defining the Molecular Landscape of Cancer-Associated Stroma in Cutaneous Squamous Cell Carcinoma.
Beebe, Erin; Motamed, Zahra; Opitz, Lennart; Cheng, Phil F; Levesque, Mitchell P; Markkanen, Enni; Feldmeyer, Laurence.
Afiliação
  • Beebe E; Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zürich, Zurich, Switzerland.
  • Motamed Z; Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zürich, Zurich, Switzerland.
  • Opitz L; Functional Genomics Center Zürich, University of Zürich/ETH Zürich, Zürich, Switzerland.
  • Cheng PF; Department of Dermatology, University of Zurich Hospital, University of Zurich, Zurich, Switzerland.
  • Levesque MP; Department of Dermatology, University of Zurich Hospital, University of Zurich, Zurich, Switzerland.
  • Markkanen E; Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zürich, Zurich, Switzerland.
  • Feldmeyer L; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: laurence.feldmeyer@insel.ch.
J Invest Dermatol ; 142(12): 3304-3312.e5, 2022 12.
Article em En | MEDLINE | ID: mdl-35850206
ABSTRACT
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer worldwide. Cancer-associated stroma (CAS) is central to tumor development and strongly influences therapy response. Perineural infiltration (PNI) represents a major risk factor for cSCC and likely influences CAS reprogramming. However, stromal reprogramming in cSCC remains poorly characterized, and it is unknown whether and how PNI influences CAS. To address these questions, we analyzed CAS and matched normal stroma from 20 cSCC cases (11 without PNI and 9 with PNI) by laser-capture microdissection using RNA sequencing. Our analysis reveals extensive stromal reprogramming strongly driven by changes in immune cells, as validated using immunohistochemistry. Furthermore, CAS of cSCC displays markers of immune exhaustion, and multiplex spatial analysis suggests that PD-L1 expression on NK T cells contributes to T-cell exhaustion and immunosuppression. Finally, PNI is characterized by increased IL-17A. In PNI-negative cases, IL-17A derives predominantly from CD3+ cells. However, with PNI, we observe an increased contribution of fibroblasts to high IL-17A, which coincides with a significant increase in FAP+ cells. Our analysis elucidates the molecular landscape of CAS in cSCC and identifies the presence of immunosuppressive mechanisms, supporting further research into immunotherapy and anti‒IL-17A in cSCC, especially for cases with PNI.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article